LAB today
$0.65+$0.01 (+1.31%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minSymmetric Triangle
Daily trend turns up above $0.67
Key levels
Resistance$0.72
Resistance$0.67
Support$0.59
Latest news & SEC filings
SEC FilingStandard Biotools Inc. filed an insider trading report (Form 4)
NewsLabrador Gold Corp. starts strategic review
NewsLabrador Gold Corp. names new executives to leadership roles
DealARCHIMED completes purchase of Standard BioTools microfluidics unit
All LAB news →About Standard BioTools
Standard BioTools provides life science research tools for proteomic and genomic analysis. Its main platforms include CyTOF and Hyperion for mass cytometry and spatial biology, plus the Biomark system for high-throughput qPCR. The company sells instruments, consumables, and services to academic institutions, research centers, clinical laboratories, and biopharmaceutical companies. It operates in North America, Europe, and Asia-Pacific, with manufacturing in Singapore and Canada.
Based on the company's 10-K filed Mar 16, 2026.
Nasdaq · Healthcare
STANDARD BIOTOOLS INC. (LAB)
What Is the Price Target for LAB?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is LAB a Buy or Sell Right Now?
Thesis
- •Revenue growing -6.2% YoY with DECLINING trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for LAB.
Start Free Trial →Is LAB Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, PEG
Fair Value
$1.50
39
Moat Score
NONE
4/9
Piotroski Score
-1.9
Altman Z-Score
What Is Smart Money Doing with LAB?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Carey Thomas D. | director | Buy | 75,000 | $47K | Nov 5, 2026 |
| Kim Hanjoon Alex | officer | Sale | 18,871 | $19K | May 20, 2026 |
| Mackay Sean | officer | Sale | 25,729 | $26K | May 20, 2026 |
| Egholm Michael | director officer | Sale | 97,626 | $98K | May 20, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →LAB Growth Story
Revenue YoY
-6.2%
3yr Revenue CAGR
-4.5%
EPS Growth YoY
61.54%
FCF Growth YoY
45.6%
Revenue Trend
DECLINING
Dark Pool Trades for LAB
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for LAB, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 12:31:29 | $0.62 | 1,000 | $$620 | SELL |
| 21:01:57 | $0.65 | 1,312 | $$855 | SELL |
| 20:43:05 | $0.65 | 4,000 | $$3K | BUY |
| 20:34:59 | $0.65 | 1,300 | $$849 | SELL |
| 20:02:56 | $0.66 | 6,000 | $$4K | SELL |
5 dark pool trades shown · $$9K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for STANDARD BIOTOOLS INC. (LAB) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →LAB — frequently asked questions
What is LAB stock price today?
STANDARD BIOTOOLS INC. (LAB) is at $0.65, up 1.31% (+$0.01) at the Nov 12, 2026 close.
Why is LAB stock moving today?
Latest LAB news — Nov 5, 2026: Standard Biotools Inc. filed an insider trading report (Form 4) · Nov 5, 2026: Labrador Gold Corp. starts strategic review
What do analysts rate LAB?
Analyst ratings for LAB: 1 Buy, 1 Hold, 0 Sell — consensus Buy.
Did LAB beat earnings?
LAB last reported on Aug 5, 2026: EPS -$0.07 vs -$0.01 expected — a miss of 446.9%.
What is LAB's P/E ratio?
LAB trades at a P/E of 2.8 vs a Healthcare average of 17.8.
Does LAB pay a dividend?
LAB does not currently pay a dividend.
What are LAB support and resistance levels?
Support: $0.59. Resistance: $0.67, $0.72, $0.80.
What are insiders doing with LAB?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on LAB?
Nov 5, 2026: Standard Biotools Inc. filed an insider trading report (Form 4) · Nov 5, 2026: Labrador Gold Corp. starts strategic review · Nov 3, 2026: Labrador Gold Corp. names new executives to leadership roles